Dr. Reddy's Laboratories Ltd. - Research Center
500124 DRREDDY Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 83.30 | 83.20 | 83.20 | 83.10 | 83.00 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 20,390.90 | 18,253.00 | 16,900.50 | 15,108.80 | 12,601.10 |
| Loan funds | |||||
| Secured loans | 0.60 | 2,171.10 | 1,180.90 | 1,062.90 | 891.70 |
| Unsecured loans | - | - | - | - | - |
| Total | 20,474.80 | 20,507.30 | 18,164.60 | 16,254.80 | 13,575.80 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 13,965.90 | 12,397.20 | 11,586.00 | 9,625.80 | 9,240.20 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 6,759.20 | 6,246.70 | 5,741.70 | 5,191.90 | 4,557.50 |
| Net block | 7,206.70 | 6,150.50 | 5,844.30 | 4,433.90 | 4,682.70 |
| Capital work-in-progress | 913.00 | 1,200.30 | 900.80 | 411.80 | 400.10 |
| Investments | 7,440.00 | 4,936.70 | 4,649.20 | 5,485.50 | 3,933.50 |
| Net current assets | |||||
| Current assets, loans & advances | 9,815.10 | 12,208.10 | 10,235.30 | 9,144.60 | 7,231.20 |
| Less : current liabilities & provisions | 4,900.00 | 3,988.30 | 3,465.00 | 3,221.00 | 2,671.70 |
| Total net current assets | 4,915.10 | 8,219.80 | 6,770.30 | 5,923.60 | 4,559.50 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 20,474.80 | 20,507.30 | 18,164.60 | 16,254.80 | 13,575.80 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | 4,033.00 |
| Market value of quoted investments | - | - | - | - | 3.80 |
| Contingent liabilities | 830.20 | 827.40 | 1,062.80 | 1,068.60 | 696.50 |
| Number of equity sharesoutstanding (Lacs) | 1665.28 | 1664.26 | 1663.01 | 1661.72 | 1660.66 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis